| Code | Description | Claims | Beneficiaries | Total Paid |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
357 |
312 |
$702K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,858 |
1,518 |
$64K |
| 96401 |
|
420 |
371 |
$43K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
58 |
54 |
$5K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
220 |
182 |
$65.92 |
| J7050 |
Infusion, normal saline solution, 250 cc |
57 |
53 |
$29.92 |
| 99072 |
|
36 |
27 |
$21.10 |